Zobrazeno 1 - 10
of 3 429
pro vyhledávání: '"A Huls"'
Autor:
CA Ortiz-Rojas, DA Pereira-Martins, CH Thomé, GA Ferreira, I Weinhauser, VMD Wagatsuma, L Pontes, G Huls, JJ Schuringa, EM Rego
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S407-S408 (2024)
Introdução: As abordagens de tratamento para a Leucemia Promielocítica Aguda (LPA) avançaram significativamente com a introdução do ácido all-trans-retinoico (ATRA) e do trióxido de arsênio (ATO). Entretanto, os mecanismos moleculares que in
Externí odkaz:
https://doaj.org/article/8442bfdd765a4f06a5f440a978d2a2b0
Autor:
MA Melo, AB Alves-Silva, NP Fonseca, I Weinhuser, ABR Bellomi, FAB Perez, LL Figueiredo-Pontes, JA Machado-Neto, L Quek, P Chatzikyriakou, GA Huls, E Ammatuna, JJ Schuringa, DA Pereira-Martins, F Traina
Publikováno v:
Hematology, Transfusion and Cell Therapy, Vol 46, Iss , Pp S473-S474 (2024)
O inibidor de JAK1/2 aprovado pela FDA, Ruxolitinibe (Ruxo), é utilizado para tratar pacientes com neoplasias mieloproliferativas (NMP), oferecendo boa tolerabilidade e redução dos sintomas constitucionais. No entanto, o efeito do Ruxo na erradica
Externí odkaz:
https://doaj.org/article/cc2fa786788e4fbdb019ff4c2c34e930
Autor:
Federico Mosna, Erika Borlenghi, Mark Litzow, John C. Byrd, Cristina Papayannidis, Cristina Tecchio, Felicetto Ferrara, Guido Marcucci, Roberto Cairoli, Elizabeth A. Morgan, Carmela Gurrieri, Cecilia C.S. Yeung, H. Joachim Deeg, Debora Capelli, Anna Candoni, Jason R. Gotlib, Monia Lunghi, Sheeja Pullarkat, Francesco Lanza, Sara Galimberti, Fabio Forghieri, Adriano Venditti, Moreno Festuccia, Ernesta Audisio, Denise Marvalle, Gian Matteo Rigolin, Giovanni Roti, Eros DiBona, Giuseppe Visani, Francesco Albano, Ann-Kathrin Eisfeld, Peter Valent, Gerwin Huls, Gautam Borthakur, Mauro Krampera, Giovanni Martinelli, Nicolaus Kröger, Alessandra Sperotto, Michele Gottardi
Publikováno v:
Haematologica, Vol 999, Iss 1 (2024)
Acute Myeloid Leukemia is mainly a disease of the elderly: however, the knowledge on the outcomes of treatment in core binding factor AML (CBFAML) in older population, is limited. We retrospectively collected data on 229 patients with CBF- AML follow
Externí odkaz:
https://doaj.org/article/f2c7a10b80a14607b116ee33cafabed3
Autor:
Zhixing Song, Jessica McMullin, Forest Huls, Richard Rosenthal, Sravani Bantu, Christopher Wu, Herbert Chen, Brenessa Lindeman
Publikováno v:
Clinical Medicine Insights: Endocrinology and Diabetes, Vol 17 (2024)
Hypercalcemia can result from either hyperparathyroidism or non-parathyroid conditions. When hypercalcemia is accompanied by undetectable parathyroid hormone (PTH) levels, hyperparathyroidism is rarely considered the diagnosis. Herein, we report the
Externí odkaz:
https://doaj.org/article/c200bb3074ca4dab989bd4e4949278a0
Publikováno v:
Communications Chemistry, Vol 7, Iss 1, Pp 1-16 (2024)
Abstract Molecular representation is critical in chemical machine learning. It governs the complexity of model development and the fulfillment of training data to avoid either over- or under-fitting. As electronic structures and associated attributes
Externí odkaz:
https://doaj.org/article/6e08415cfa8c45a09023db04a2e550bc
Autor:
Hester F Lingsma, David van Klaveren, Arjan A van de Loosdrecht, Anna van Rhenen, Otto Visser, Valery E P P Lemmens, Nikki van Leeuwen, Gerwin Huls, Z L Rana Kaplan, Eduardus F M Posthuma, Danielle van Lammeren-Venema, Tjeerd J F Snijders, Catharina H M J van Elssen, Peter A von dem Borne, Nicole M A Blijlevens, Jan J Cornelissen, Marc H G P Raaijmakers, Avinash G Dinmohamed
Publikováno v:
BMJ Oncology, Vol 3, Iss 1 (2024)
Objective Acute myeloid leukaemia (AML) prognosis is enhanced with intensive remission induction chemotherapy (ICT) in eligible patients. However, ICT eligibility perceptions may differ among healthcare professionals. This nationwide, population-base
Externí odkaz:
https://doaj.org/article/1ccfa978daa64b508cdfbda59b2174a6
Autor:
Huang, Xiang, Huls, Rachel N.
Bournez, Fraigniaud, and Koegler defined a number in [0,1] as computable by their Large-Population Protocol (LPP) model, if the proportion of agents in a set of marked states converges to said number over time as the population grows to infinity. The
Externí odkaz:
http://arxiv.org/abs/2206.06594
Autor:
Tienstra, Marieke, de Boer, Janneke W., van Doesum, Jaap A., Keijzer, Kylie, Morsink, Linde M., Hazenberg, Carin L.E., Ammatuna, Emanuele, Huls, Gerwin A., Choudhary, Pratik, Gans, Rijk O.B., Wiersma, Valerie R., van Meerten, Tom, van Dijk, Peter R.
Publikováno v:
In Endocrine Practice December 2024 30(12):1141-1148
Autor:
Maria L. Salustiano-Bandeira, Amanda Moreira-Aguiar, Diego A. Pereira-Martins, Juan L. Coelho-Silva, Isabel Weinhäuser, Pedro L. França-Neto, Aleide S. Lima, Ana S. Lima, Anemari R. Baccarin, Fernanda B. Silva, Manuela A. de Melo, Fernanda S. Niemann, Luciana Nardinelli, César A. Ortiz Rojas, Bruno K. Duarte, Aderson S. Araujo, Elisa A. Azevedo, Clarice N. Morais, Lorena L. Figueiredo-Pontes, Jan J. Schuringa, Gerwin Huls, Israel Bendit, Eduardo M. Rego, Sara T. Olalla Saad, Fabiola Traina, Marcos A. Bezerra, Antonio R. Lucena-Araujo
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-3 (2024)
Externí odkaz:
https://doaj.org/article/67ef150b7ee54451934361d769848375
Autor:
Niek G. van der Maas, Jurjen Versluis, Kazem Nasserinejad, Joost van Rosmalen, Thomas Pabst, Johan Maertens, Dimitri Breems, Markus Manz, Jacqueline Cloos, Gert J. Ossenkoppele, Yngvar Floisand, Patrycja Gradowska, Bob Löwenberg, Gerwin Huls, Douwe Postmus, Francesco Pignatti, Jan J. Cornelissen
Publikováno v:
Blood Cancer Journal, Vol 14, Iss 1, Pp 1-7 (2024)
Abstract Randomized controlled trials (RCTs) are the gold standard to establish the benefit-risk ratio of novel drugs. However, the evaluation of mature results often takes many years. We hypothesized that the addition of Bayesian inference methods a
Externí odkaz:
https://doaj.org/article/623b04e635e3492980510900ad96507c